This study was conducted to assess outcomes (according to patency) of vasectomy reversal (VR) in qualified patients with postvasectomy pain syndrome (PVPS). A total of 32 patients with PVPS undergoing VR between January 2000 and May 2010 were examined retrospectively. Of these, 68.8% (22/32) completed a study questionnaire, either onsite at the outpatient clinic or via telephone interview. Preoperative clinical findings, preoperative and postoperative visual analogue scale (VAS) pain scores, patency and pregnancy rate and overall patient satisfaction were analyzed. For the latter, a four-point rating of (1) cure, (2) improvement, (3) no change or (4) recurrence was used. The mean age was 45.09±4.42 years and the mean period of follow-up was 3.22 years (0.74--7.41). Patency rates were 68.2% (15/22) and pregnancy rates were 36.4% (8/22). The mean VAS was 6.64 ± 1.00 preoperatively and 1.14 ± 0.71 postoperatively (Po0.001). The difference in the mean preoperative and postoperative VAS was 6.00±1.25 (4--8) in the patency group and 4.43±0.98 (3--6) in the no patency group (P ¼ 0.011). A significant difference in procedural satisfaction with surgical outcome was observed between patency and no patency groups (P ¼ 0.014). In conclusion, in PVPS patients requiring VR, a significant difference was observed between the patency and no patency groups in terms of pain reduction and the degree of patient procedural satisfaction.
INTRODUCTION
An estimated 40--60 million men worldwide have undergone vasectomy, accounting for 5--10% of birth control methods currently in use. 1 When a government-backed family planning project launched in 1960, the rate of vasectomy in Korea climbed. More than 100 000 fertile men had opted for this procedure by the early 1980s. However, the number of procedures has gradually decreased since the 1990s due to changing government policy and the introduction of multiple-birth family planning. 2 Chronic scrotal pain following vasectomy, by definition, is persistent (either intermittent or constant) 3 and ranges from a selflimiting affliction to one that requires medical or surgical intervention. 4 First-line treatment typically entails reassurance, scrotal support, nonsteroidal antiinflammatory drugs and nonsurgical interventions, such as local injection with lidocaine. Patients failing conservative management may turn to surgical options, including testicular-sparing therapies such as spermatic cord denervation (SCD), removal of sperm granuloma, epididymectomy and vasectomy reversal (VR)---vasovasostomy and vasoepididymostomy, or orchiectomy. 5 Over the past 40 years, research into the scope of postvasectomy chronic scrotal pain has increased. Alternative terms for this syndrome include congestive epididymitis, 6 postvasectomy orchalgia 7 and late postvasectomy syndrome. 8 More recently, the term postvasectomy pain syndrome (PVPS) was introduced. 9 Few studies have explored outcomes of VR, as a function of patency, for PVPS refractory to conservative measures. The aim of this study therefore was to compare results of VR and assess procedural satisfaction in patients stratified by patency.
PATIENTS AND METHODS
Retrospectively, we examined patients electing VR for fertility recovery, performed at one of four medical institutions between January 2000 and May 2010. Patients selected for study had experienced chronic epididymal pain of 43-months duration, without response to a conservative approach (nonsteroidal antiinflammatory drugs, tramadol, opioid, lidocaine injection, and so on) for a minimum of 3 weeks after initial outpatient contact. The study was approved from the Ethical Review Committee of the hospital.
Surgical procedure
A total of 331 patients underwent vasovasostomy in the specified study period who wished to primarily recover fertility underwent VR during the study period. Of these, 32 (9.7%) complained of chronic scrotal pain adjacent to epididymis on physical examination. Our postoperative questionnaire was completed by 68.8% (22/32) of the latter group. One patient had bilateral PVPS.
Under general or spinal anesthesia, the seminal tubule was first exposed and fixed with towel clips. The vas deferens was then located and the vasectomy nodule dissected. Upon visualizing the lumen of the vas, its proximal and distal ends were approximated. Given detectable vasal fluid (17 patients), bilateral modified single-layer vasovasostomy was undertaken via microscope. If the fluid was thick, pasty and devoid of sperm under a light microscope, a vasoepididymostomy was performed. Vasoepididymostomy was otherwise performed for the remaining five patients with no observable vasal fluid. Bilateral vasoepididymostomy was performed in two patients and unilateral vasoepididymosotomy and contralateral vasovasostomy were performed in three patients.
Statistical analysis
In the study population, the following analyses were conducted: (i) the duration of preoperative pain, (ii) preoperative physical signs, (iii) preoperative and postoperative visual analogue scale (VAS) pain scores, (iv) patency and pregnancy rate and (v) patient satisfaction. Outpatient clinic attendees were asked to complete a written questionnaire based on VAS, while those not attending could respond by phone using a verbal numeric rating scale (VNRS) pain score. The severity of pain was rated using a scale of 0--10, with 0 indicating pain-free status and 10 representing the worst pain imaginable. A VNRS and VAS were considered equivalent. As with prior studies, surgical outcomes were rated as cure, improvement, no change or recurrence. 10--12 Mann--Whitney U-test was used for age, duration of pain, mean period of outpatient follow-up and VAS score analyses, while treatment outcome was assessed with Fisher's exact test. 
RESULTS
A total of 32 patients underwent VR for PVPS. Of these, 22 (68.8%) completed the study questionnaire either at the outpatient clinic (n ¼ 8) or during a telephone interview (n ¼ 14), including one respondent with bilateral PVPS. Mean age of the patient sampling was 45.09±4.42 years. The mean duration of pain was 5.18±2.02 years, while the mean period of follow-up was 3.32 years (0.74--7.41). The mean period of postvasectomy was 11.09 ± 3.34 years. Analysis of semen from men achieving vasal patency was performed at month 6 after surgery, showing sperm concentrations of 20.1 million ml À1 (8.0--32.0 million ml
À1
) and sperm motilities of 35.7% (15--80%). Patency rates were 68.2% (15 out of 22) and pregnancy rates were 36.4% (8 out of 22). In the patency group (n ¼ 15), mean age was 43.80±4.20 years, while without patency (n ¼ 7), mean age was 47.86 ± 3.76 years (P ¼ 0.033). The difference in the mean duration of pain between patency and no-patency groups was 4.80±2.21 and 5.42±1.29 years, respectively (P ¼ 0.185), with a mean follow-up times of 3.45 years (0.74--6.48) and 3.04 years (1.68--7.41), respectively (P ¼ 0.620). In patency and no-patency groups, the mean period of postvasectomy was 9.60 ± 2.10 years and 14.28 ± 3.35 years, respectively (P ¼ 0.006). Baseline characteristics of the study population are shown in Table 1 .
Overall, the mean preoperative and postoperative VAS scores were 6.64 ± 1.00 and 1.14 ± 0.71, respectively (Po0.001). The mean preoperative VAS score was 6.87±0.99 (5--8) in the patency group and 6.14±0.90 (5--7) for those with no-patency (P ¼ 0.133); postoperatively mean VAS scores were 0.87 ± 0.64 (0--2) and 1.71 ± 0.49 (1--2), respectively (P ¼ 0.008). The mean change in the preoperative and postoperative VAS scores was 6.00±1.25 (3--6) with patency and 4.43 ± 0.98 (4--8) without patency (P ¼ 0.011). Statistical significance of the preoperative and postoperative VAS scores and of the difference in the preoperative and postoperative scores is shown in Table 1 .
Overall surgical outcomes were as follows: (i) cured, 15 patients (68.2%); (ii) improved, 7 patients (31.8%); (iii) no change, none (0%); and (iv) recurrence, none (0%). In the patency group, 13 patients (86.7%) were reported as cured and 2 patients (13.3%) as improved, while in the no-patency group, 2 patients (28.6%) were designated cured and 5 (71.4%) as improved. The difference in treatment outcomes of the two groups was statistically significant (P ¼ 0.014; Figure 1 ). Of the five patients undergoing vasoepididymostomy, three responded as 'cured' and three as 'improved' according to survey. 
DISCUSSION
The incidence of major postvasectomy complications is estimated at 2--3%, 13 with bleeding, hematoma, superficial infection and wound separation constituting potential problems early on. PVPS, as one form of chronic scrotal pain, is the most common late complication of vasectomy 14 and may affect up to 30% of cases. Long-term pain, often in the epididymal region and warranting surgical treatment, occurs in B0.1% of patients. 3, 15 The fact that PVPS typically involves areas of the genital tract adjacent to the vasectomy site has generated at least two pathophysiologic hypotheses. The first theory cites dilatation and obstruction of the epididymal duct, triggering interstitial fibrosis, as the basis of PVPS. The other proposed mechanism is that perineural fibrosis develops following rupture of the epididymal duct, accompanied by extravasation of sperm near epididymal tubule and the vasal transection site. 3 If correct, areas adjacent to vas deferens should show histopathological evidence of vasitis and epididymitis nodosa. Although sperm granulomas (inherently fibrotic) may be formed in roughly 70% of all vasectomy cases, they are mostly asymptomatic. Furthermore, above changes are widely reported in patients requiring no specific treatment. 16 Testicular-sparing procedures commonly used for PVPS include vasovasostomy and vasoepididymostomy, epididymectomy and SCD. However, these treatments have not been fully investigated, and existing data are from small patient cohorts. Myers et al. 17 performed microsurgical vasovasostomy or vasoepididymostomy in 32 patients with PVPS, all of whom presented with a unilateral or bilateral testicular pain exacerbated by sexual arousal, intercourse or ejaculation. Most of them (75%) reported complete postoperative pain relief for a mean follow-up of 2.4 years, while pain persisted or recurred for the remaining eight patients. Nangia et al.
15 also performed vasovasostomy in 13 patients with PVPS, all of whom had failed prior nonsurgical intervention. A multilayer microsurgical anastomosis technique was used. Nine of these patients were pain-free postoperatively, while four experienced partial pain relief. More recently, Huang et al. 18 performed microsurgical vasovasostomy in four patients, three of whom were pain-free postoperatively; but there have been no studies on the efficacy of VR according to patency rate, raising the question of a selection bias when interpreting results. To our knowledge, this study is the first to examine patency in conjunction with efficacy of VR in patients with PVPS.
Epididymectomy is another surgical option for PVPS. Lee et al. 19 recently reported epididymectomy outcomes in patients with PVPS, chronic epididymitis and painful epididymal cysts, concluding that it is an effective treatment for all three conditions. Hori et al. 20 also studied long-term results after epididymectomy for PVPS. 20 Of 45 patients, 42 (93.3%) were pain-free postoperatively and were pleased with the results. Siu et al. 21 likewise claimed 100% patient satisfaction in 25 patients with PVPS undergoing epididymectomy. Furthermore, Sweeney et al. 22 reported a satisfaction level of 87.5% with this technique, recording best overall outcomes in the PVPS group, while Chen and Ball 23 indicated that 5 of 10 patients with PVPS (50%) were pain-free after epididymectomy. In spite of these successes, epididymectomy with PVPS remains controversial. Sweeney et al. 24 found that in a larger study group (n ¼ 34), only 5 of 17 patients with PVPS (29%) responded favorably after epididymectomy.
Although reports are fewer than with VR or epididymectomy, and larger patient samplings are needed, SCD has been used alternatively for PVPS. Heidenreich et al. 25 reported outcomes of SCD for six patients with PVPS. The procedure involved coagulation (bipolar diathermy) and transection in areas adjacent to testicular artery, vas deferens and one or two lymphatic vessels. All PVPS patients were pain-free postoperatively, as were those evaluated in similar studies by Devine et al. 26 and Levine et al. 27 When Cadeddu et al. 28 performed laparoscopic testicular denervation in six patients with PVPS, the postoperative pain-free rate was again 100%.
All 22 respondents undergoing VR for PVPS in this study achieved statistically significant reductions in pain and were satisfied with their treatment outcomes. Our results paralleled other recent studies of VR and were comparable with outcomes following alternative testicular-sparing therapies such as epididymectomy or SCD (Table 2) . On the other hand, a significant difference in pain reduction, as measured by the VAS pain scores, was observed when patients with and without patency were compared. Patency may, in fact, correlate with patient age, postvasectomy duration, postoperative pain reduction and patient procedural satisfaction. VR with patency may thus be more effective in reducing pain in patients with PVPS, compared with loss of patency. Consequently, optimal use of VR may be younger PVPS patients of shorter postvasectomy status who wish to recover fertility. A limitation of this study is that it was conducted retrospectively, leaving room for recall and selection bias. All of the patients primarily wanted recovery of fertility, so that issues of patency may have overshadowed other factors. In addition, there is the possibility of placebo effect, and with all questionnairebased studies, it is possible that remarks of patients responding by phone may have taken a more positive turn. Intraoperative vasal fluid detection and postoperative recovery of fertility may also have had some bearing on surgical outcome and patient satisfaction. Although VAS is generally regarded as a valid and reliable tool for chronic pain measurement, 29 these scores could conceivably reflect long-term memory or other inaccuracies, and correlation between VNRS and VAS has been imperfect in previous studies. 30 Results of patency may influence VAS. A cognitive assessment such as a pain score may be highly influenced by other cognitive factors. Correlation between patency and scrotal pain might be resulted in bias. It is also the limitation of our study. In addition, low patency rate of our patients should be contemplated in PVPS patients. Reason for low patency in PVPS will be turn out to be a scientific value using histological methodology or large-scale prospective study.
Despite these limitations, this study is the first to attempt comparison of postoperative VR efficacy, stratified by patency, in patients with PVPS. Duration of follow-up was longer and patient cohort was larger than in any previous studies of VR. As such, further prospective analysis of various surgical treatments in patients with PVPS is justified.
CONCLUSIONS
VR is an option for PVPS when first-line conservative management fails. In this study, VR was effective in reducing pain for such patients, generating uniformly high-level satisfaction with surgical outcomes. Present data also underscore a significant therapeutic difference, depending on whether or not patency is preserved. VR should therefore be considered in patients with PVPS who are young, wish to recover their fertility and are of shorter postvasectomy duration.
